PDGFRA and central nervous system cancer: Recently, enriched PDGFRA expression was reported in the proneural GBM subtype which was seen to be associated with a better prognosis compared to the other molecular subtypes of GBM [25], [26], while other studies reported no correlation between PDGFRA expression and clinical-pathological parameters of glioma patients [14].